A new FDA-approved drug brings in a lot of hope for men with aggressive prostate cancer, as it may increase their chances of survival by 40 per cent. According to experts, the combination of two drugs ...
Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients ...
The known prostate cancer drug, Abiraterone, will be accessible for patients in the coming week, after a campaign led by a ...
Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...
Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.
The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.
CNN — (CNN) — President Joe Biden’s diagnosis of metastatic prostate cancer has understandably raised concerns and questions: How long has he had cancer, how will he be treated, and what is his ...
PROSTATE cancer has become the most common form of the disease in Britain for the first time. Analysis of NHS figures by ...
Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results